Aminodihydrothiazine derivatives as BACE inhibitors for the treatment of Alzheimer's disease

Details for Australian Patent Application No. 2009241515 (hide)

Owner Eli Lilly and Company

Inventors Mergott, Dustin James; Watson, Brian Morgan; Sheehan, Scott Martin; Audia, James Edmund

Agent Spruson & Ferguson

Pub. Number AU-B-2009241515

PCT Pub. Number WO2009/134617

Priority 61/049,881 02.05.08 US

Filing date 15 April 2009

Wipo publication date 5 November 2009

Acceptance publication date 19 April 2012

International Classifications

C07D 279/06 (2006.01) Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms

A61K 31/541 (2006.01) - Non-condensed thiazines containing further heterocyclic rings

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

Event Publications

21 October 2010 PCT application entered the National Phase

  PCT publication WO2009/134617 Priority application(s): WO2009/134617

19 April 2012 Application Accepted

  Published as AU-B-2009241515

16 August 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009241516-Oxidative hair dye compositions, methods and products

2009241514-Novel inhibitors of hepatitis C virus replication